news-med.jpg

Evotec and Celgene expand IPSC collaboration to include additional cell lines

$ 6 M payment to access additional cell lines

Topics: Corporate, Evotec, Celgene, IPSC, Induced pluripotent stem cells Read More

Evotec and Celgene enter partnership in the field of targeted protein degradation

The collaboration will focus on targeted protein degradation Evotec's panomics and data analytics platforms will be leveraged Financials include upfront payment as well as significant potential milestone-based payments and royalties

Topics: Corporate, Evotec, Celgene Read More

Evotec and Celgene expand IPSC collaboration to include additional cell lines

$ 6 M payment to access additional cell lines

Topics: Corporate, Celgene, IPSC, Evotec Read More

Evotec and Celgene enter into strategic oncology partnership

Leveraging Evotec's phenotypic screening capabilities and compound libraries with an initial focus on solid tumours Upfront payment of $ 65 M, significant milestone payments and tiered royalties per programme

Topics: Corporate, Celgene, Oncology Read More

Most Read

Posts by Topic